Loading clinical trials...

A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China | Clinical Trials | Clareo Health

Enrolling By InvitationNCT06101940

A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China

Myotonic dystrophy 1 (DM1) is an autosomal, dominantly inherited neuromuscular disorder characterized by skeletal muscle weakness, myotonia, cardiac conduction abnormalities, cataracts, and other abno...

Lead sponsor: Huashan Hospital•22 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

Study of ATX-01 in Participants With DM1

NCT06300307 · Myotonic Dystrophy 1

RECRUITINGPhase 3

Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)

NCT05532813 · Steinert's Disease, Myotonic Dystrophy 1, and more

RECRUITINGNA

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more

RECRUITING

Myotonic Dystrophy Family Registry

NCT02398786 · Myotonic Dystrophy, Congenital Myotonic Dystrophy, and more

Enrolling By InvitationPhase 3

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469 · Myotonic Dystrophy Type 1, DM1, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 16, 2025Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment500

Start dateAug 2021

Last updatedSep 16, 2025

Condition

Myotonic Dystrophy 1

Locations shown

Chinese People's Liberation Army General Hospital

Beijing, Beijing Municipality

Peking University First Hospital

Beijing, Beijing Municipality

First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 16, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions